Globe Newswire

Form 8.5 (EPT/RI) - Touchstone Exploration Inc. Jul 3, 2024 04:22AM

FORM 8.5 (EPT/RI)

PUBLIC DEALING DISCLOSURE BY AN EXEMPT PRINCIPAL TRADER WITH RECOGNISED INTERMEDIARY STATUS DEALING IN A CLIENT-SERVING CAPACITY Rule 8.5 of the Takeover Code (the “Code”)

1.        KEY INFORMATION

(a)        Name of exempt principal trader:Shore Capital Stockbrokers Ltd(b)        Name of offeror/offeree in relation to whose relevant securities this form relates:         Use a separate form for each offeror/offereeTouchstone Exploration... (continue reading...)

Chinese leading power producer SPIC highlights cross-border nuclear energy partnership in Türkiye Jul 3, 2024 04:01AM

ISTANBUL, July 03, 2024 (GLOBE NEWSWIRE) -- The Nuclear Power Plants VI. Expo & X. Summit opened in Istanbul, Türkiye on July 2. State Power Investment Corporation Limited (SPIC), one of China's top five power producers, was invited to participate in the event for the 10th time.

A Media Snippet accompanying this announcement is available by clicking on this link.

During the two-day event, the Shanghai Nuclear Engineering Research & Design Institute, entrusted by... (continue reading...)

InterDigital Announces Convertibility of 3.50% Senior Convertible Notes Due 2027 Jul 3, 2024 04:00AM

WILMINGTON, Del., July 03, 2024 (GLOBE NEWSWIRE) -- InterDigital, Inc. (Nasdaq: IDCC), a mobile, video and AI technology research and development company, announced today that, pursuant to the terms of the Indenture governing its 3.50% Senior Convertible Notes due 2027 (the “Notes”), the Notes are convertible during its calendar quarter ending September 30, 2024. The current conversion rate of the Notes is 12.9041 shares of InterDigital’s Common Stock per $1,000... (continue reading...)

Pneumagen Highlights Broad-Spectrum Antiviral Activity of First-in-Class Intranasal Drug Neumifil in New Publication Jul 3, 2024 04:00AM

• Pneumagen has previously reported positive results from both Phase 1 and a clinical proof of concept Phase 2 Human Influenza Challenge study demonstrating the potential of Neumifil
• New preclinical data, published in peer-reviewed journal Antiviral Research, show Neumifil demonstrates broad-spectrum efficacy against a wide range of viruses including influenza virus, respiratory syncytial virus, coronavirus and rhinovirus
• These studies confirm Neumifil’s ability to block... (continue reading...)

Nycrypto Labs Raises $800K to Launch and Scale Tidus, the Crypto Everything App Jul 3, 2024 04:00AM

Tidus: The First Multi-Chain, Multi-Layer, Non-Custodial Wallet to Offer In-App Lending, Borrowing, Swapping, and Staking While Mitigating Bridging Risks

New York, NY, July 03, 2024 (GLOBE NEWSWIRE) -- Nycrypto Labs, a blockchain development hub dedicated to simplifying the transition from Web2 to Web3, announced today that it has raised $800,000 in pre-seed funding. The round was led by DNA Fund, with participation from Michael Terpin’s Transform Ventures and a host... (continue reading...)